POSTER: ABCL-478 Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study

Michael Dickinson; Carmelo Carlo-Stella; Franck Morschhauser; Emmanuel Bachy; Paolo Corradini; Gloria Iacoboni; Cyrus Khan; Thomasz Wróbel; Fritz Offner; Marek Trněný; Shang-Ju Wu; Guillaume Cartron; Mark Hertzberg; Anna Sureda; David Perez-Callejo; Linda Lundberg; James Relf; Emma Clark; Kathryn Humphrey; Martin Hutchings

doi:10.1016/S2152-2650(23)00735-8

$POSTER: ABCL-478 Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study$

Article de revue

Avec comité de lecture

POSTER: ABCL-478 Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study

Michael Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Thomasz Wróbel, Fritz Offner, Marek Trněný, …

Clinical lymphoma, myeloma and leukemia, Vol.23, pp.S206-S206

09/2023

DOI: https://doi.org/10.1016/S2152-2650(23)00735-8

Indicateurs

1 Consultations de la notice

Détails

Titre: POSTER: ABCL-478 Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study
Créateurs - sans rôle: Michael Dickinson - The University of Melbourne
Carmelo Carlo-Stella - Humanitas University
Franck Morschhauser - Hôpital Claude Huriez
Emmanuel Bachy - Hôpital Lyon Sud
Paolo Corradini - Istituti di Ricovero e Cura a Carattere Scientifico
Gloria Iacoboni - Hebron University
Cyrus Khan - Allegheny Health Network
Thomasz Wróbel - Uniwersytet Medyczny we Wrocławiu, Wroclaw, Poland
Fritz Offner - Universitair Ziekenhuis Gent, Ghent, Belgium
Marek Trněný - Charles University
Shang-Ju Wu - National Taiwan University Hospital, Taipei, Taiwan
Guillaume Cartron - CHU de Montpellier, Montpellier, France
Mark Hertzberg - UNSW Sydney
Anna Sureda - Institut Català d'Oncologia
David Perez-Callejo - F. Hoffmann-La Roche Ltd, Basel, Switzerland
Linda Lundberg - F. Hoffmann-La Roche Ltd, Basel, Switzerland
James Relf - Roche Products Ltd, Welwyn Garden City, United Kingdom
Emma Clark - Roche Products Ltd, Welwyn Garden City, United Kingdom
Kathryn Humphrey - Roche Products Ltd, Welwyn Garden City, United Kingdom
Martin Hutchings - Rigshospitalet
Détails de publication: Clinical lymphoma, myeloma and leukemia, Vol.23, pp.S206-S206
Éditeur: Elsevier Inc
Identifiants: 99139652809311
Unité académique: Institut de Génétique Moléculaire de Montpellier - IGMM
Langue: English
Type de ressource: Journal article